Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.979
-0.009 (-0.87%)
At close: Dec 20, 2024, 4:00 PM
1.060
+0.081 (8.32%)
After-hours: Dec 20, 2024, 7:12 PM EST
Opus Genetics Employees
Opus Genetics had 14 employees as of December 31, 2023. The number of employees increased by 5 or 55.56% compared to the previous year.
Employees
14
Change (1Y)
5
Growth (1Y)
55.56%
Revenue / Employee
$598,643
Profits / Employee
-$1,942,286
Market Cap
30.89M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14 | 5 | 55.56% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | 8 | 3 | 60.00% |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adagio Medical Holdings | 85 |
| NextCure | 82 |
| Enlivex Therapeutics | 71 |
| DURECT | 58 |
| KALA BIO | 43 |
| LAVA Therapeutics | 37 |
| Femasys | 34 |
| Longeveron | 24 |
IRD News
- 2 days ago - Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy - GlobeNewsWire
- 5 weeks ago - Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire